This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript
BMC Medical Genomics Open Access 05 February 2022
-
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
Journal of Cancer Research and Clinical Oncology Open Access 07 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukaemia phenotype. Blood 1996; 88: 2375–2384.
Demehri S, Paschka P, Schultheis B, Lange T, Koizumi T, Sugimoto T et al. e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants? Leukemia 2005; 19: 681–684.
Gabert J, Beillard E, van der Veden VHJ, Bi W, Grimwade D, Pallisgaard N et al. Standardisation and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) of fusion gene transcripts for residual disease detection in leukaemia – A Europe Against Cancer Program. Leukemia 2003; 17: 2318–2357.
Branford S, Rudzki Z, Hughes TP . A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 2000; 109: 635–637.
Sugimoto T, Ijima K, Hisatomi H, Murayama T, Mizuno I, Hato A et al. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence. Am J Hematol 2004; 77: 164–166.
Martinelli G, Terragna C, Amabile M, Montefusco V, Testoni N, Ottaviani E et al. Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2). Leukemia 1999; 13: 1635–1637.
Martinelli G, Terragna C, Amabile M, Montefusco V, Testoni N, Ottaviani E et al. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints. Haematologica 2000; 85: 40–46.
Le Roy C, Wrana JL . Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005; 6: 112–126.
Hochhaus A, La Rosée P . Imatinib therapy in chronic myelogenous leukemia : strategies to avoid and overcome resistance. Leukemia 2004; 18: 1321–1331.
Acknowledgements
This work was supported by the Hospices Civils de Lyon, Ligue contre le cancer du Rhône (to SH, FEN, KC) and a grant from Cancéropôle Lyon Auvergne Rhône-Alpes (CLARA) 2003 (to SH, FEN). We thank Annick Bertholin for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cayuela, J., Rousselot, P., Nicolini, F. et al. Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib. Leukemia 19, 2334–2336 (2005). https://doi.org/10.1038/sj.leu.2403986
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403986
This article is cited by
-
A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript
BMC Medical Genomics (2022)
-
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
Journal of Cancer Research and Clinical Oncology (2021)